Literature DB >> 1703303

Isolation and characterization of the genomic human CD7 gene: structural similarity with the murine Thy-1 gene.

L E Schanberg1, D E Fleenor, J Kurtzberg, B F Haynes, R E Kaufman.   

Abstract

The human CD7 molecule is a 40-kDa member of the immunoglobulin gene superfamily that is expressed on T-lymphoid and myeloid precursors in fetal liver and bone marrow. CD7 is also expressed on T lymphocytes in multiple stages of T-cell development, including a major subset of mature peripheral T cells. In this paper we report the isolation and characterization of the human CD7 gene and 5' flanking region. Sequence analysis revealed that the CD7 gene comprises four exons that span 3.5 kilobases. The 5' flanking region (506 base pairs) has a high G + C content and no "TATA" or "CCAAT" elements. DNase I sensitivity analysis of chromatin from the CD7+ progenitor cell leukemia line, DU528, and the CD7-, CD4+, CD8+, TCR alpha beta + T-cell line, DU980 (where TCR is the T-cell receptor), revealed two distinct hypersensitive sites 5' of the CD7 gene. Hypersensitive site 1, present in the DU980 T-cell line, was located 4.5 kilobases upstream of the presumed CD7 transcription initiation site. Only DNase I hypersensitive site 2, which mapped to the promoter region, was found in the DU528 line. Comparison of the organization of the CD7 gene with that of other members of the immunoglobulin gene superfamily revealed that the human CD7 gene most closely resembles the murine Thy-1 gene. Both CD7 and Thy-1 are encoded by small genes with four exons, contain TATA-less promoters, and have a similar functional organization. These structural similarities suggest that human CD7 and murine Thy-1 may be functional homologues.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1703303      PMCID: PMC50860          DOI: 10.1073/pnas.88.2.603

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

Review 1.  Organization of the human class I major histocompatibility complex genes.

Authors:  B H Koller; D Geraghty; H T Orr; Y Shimizu; R DeMars
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

2.  Identification of negative and positive regulatory elements associated with a class I major histocompatibility complex gene.

Authors:  R Ehrlich; J E Maguire; D S Singer
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

3.  A constitutive promoter directs expression of the nerve growth factor receptor gene.

Authors:  A Sehgal; N Patil; M Chao
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

4.  Characterization of two atypical promoters and alternate mRNA processing in the mouse Thy-1.2 glycoprotein gene.

Authors:  H A Ingraham; G A Evans
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

5.  The human Thy-1 gene: structure and chromosomal location.

Authors:  T Seki; N Spurr; F Obata; S Goyert; P Goodfellow; J Silver
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

6.  Simian virus 40-mediated cis induction of the Xenopus beta-globin DNase I hypersensitive site.

Authors:  T Enver; A C Brewer; R K Patient
Journal:  Nature       Date:  1985 Dec 19-1986 Jan 1       Impact factor: 49.962

7.  The mouse Thy-1.2 glycoprotein gene: complete sequence and identification of an unusual promoter.

Authors:  H A Ingraham; G M Lawless; G A Evans
Journal:  J Immunol       Date:  1986-02-15       Impact factor: 5.422

8.  Characterization of the promoter region and 3' end of the human insulin receptor gene.

Authors:  D S Tewari; D M Cook; R Taub
Journal:  J Biol Chem       Date:  1989-09-25       Impact factor: 5.157

9.  Human thy-1: unusual localization and possible functional significance in lymphoid tissues.

Authors:  J L McKenzie; J W Fabre
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

10.  Structure of the murine Thy-1 gene.

Authors:  V Giguére; K Isobe; F Grosveld
Journal:  EMBO J       Date:  1985-08       Impact factor: 11.598

View more
  10 in total

1.  A duplicated motif controls assembly of zona pellucida domain proteins.

Authors:  Luca Jovine; Huayu Qi; Zev Williams; Eveline S Litscher; Paul M Wassarman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-12       Impact factor: 11.205

2.  Molecular cloning of the gene coding for the mouse T-cell antigen CD7.

Authors:  K Yoshikawa; M Seto; R Ueda; Y Obata; S Aoki; T Takahashi
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

3.  Genomic organization of the mouse B-lymphocyte activation antigen B7.

Authors:  A Selvakumar; P C White; B Dupont
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

Review 4.  CD4+ CD7- T cells: a separate subpopulation of memory T cells?

Authors:  U Reinhold; H Abken
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

5.  Genomic structure of the human CD53 gene.

Authors:  V Korínek; V Horejsí
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

6.  Molecular cloning and expression analysis of pig CD7.

Authors:  Ju Yeon Lee; Joonbeom Bae; Inho Choi; Chung-Gyu Park; Taehoon Chun
Journal:  Vet Res Commun       Date:  2014-05-03       Impact factor: 2.459

7.  Genomic organization and chromosomal location of the human gene encoding the B-lymphocyte activation antigen B7.

Authors:  A Selvakumar; B K Mohanraj; R L Eddy; T B Shows; P C White; B Dupont
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

8.  Isolation and characterization of mouse CD7 cDNA.

Authors:  K Yoshikawa; M Seto; R Ueda; Y Obata; H Fukatsu; A Segawa; T Takahashi
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

9.  Single-cell isoform analysis in human immune cells.

Authors:  Roger Volden; Christopher Vollmers
Journal:  Genome Biol       Date:  2022-02-07       Impact factor: 13.583

10.  CD7 expression in malignant pleural mesothelioma.

Authors:  S Hibi; Y Kataoka; N Fujita; H Okabe; K Yoshikawa; M Seto; R Ueda; S Imashuku
Journal:  Jpn J Cancer Res       Date:  1992-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.